Skip to main content

Table 1 Baseline prevalence and intensity of S. haematobium infection

From: Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity

Parameter

S. haematobium

infected

S. haematobium

uninfected

χ2

P value

Light Infection

Moderate Infection

Heavy Infection

χ2

P value

Sex

  

1.891

0.169

   

0.297

0.862

 Boys

20 (19%)

85 (81%)

  

11 (55%)

7 (35%)

2 (10%)

  

 Girls

29 (27.1%)

78 (72.9%)

  

20 (69%)

7 (24.1%)

2 (6.9%)

  

Age Group

  

0.158

0.691

   

2.594

0.273

 7–9

19 (20%)

76 (80%)

  

13 (68.4)

4 (21.1%)

2 (10.5%)

  

 10–13

30 (25.6%)

87 (74.4%)

  

18 (60%)

10 (33.3%)

2 (6.7%)

 Â